Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)

Myomo has reported Asset Writedowns and Impairment for 8 years, with the latest figure at $103779.0 in Q3 2025.

• For the quarter ending Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $103779.0; the trailing twelve-month figure through Sep 2025 stood at $193822.0 (up 821.56% YoY), and the FY2024 full-year result was $43657.0, up 53.72% from the prior year.
• Asset Writedowns and Impairment for Q3 2025 stood at $103779.0, up from $51643.0 in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $103779.0 in Q3 2025, with the low at -$374.0 in Q3 2023.
• Historically, Asset Writedowns and Impairment has averaged $31694.4 across 4 years, with a median of $20925.0 in 2022.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment sank 50.14% — and 2024, when it soared 143.42%.
• Myomo's Asset Writedowns and Impairment stood at $26075.0 in 2022, then tumbled by 39.5% to $15775.0 in 2023, then soared by 143.42% to $38400.0 in 2024, then surged by 170.26% to $103779.0 in 2025.
• The last three Asset Writedowns and Impairment figures came in at $103779.0 (Q3 2025), $51643.0 (Q1 2025), and $38400.0 (Q4 2024), per Business Quant data.